Mayne Pharma reported $103.76M in Cost of Sales for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Ansell ANN:AU $ 683.8M 26.5M
Cochlear COH:AU $ 202.9M 5.4M
CSL CSL:AU $ 2.59B 393M
Ecofibre Ltd EOF:AU 6.98M 945K
Healius Ltd HLS:AU $ 173.3M 36.9M
Integral Diagnostics Ltd IDX:AU 9.3M 544K
Nanosonics Ltd NAN:AU $ 14.24M 456K
Next Science Ltd NXS:AU 1.17M 331.29K
Polynovo Ltd PNV:AU 781.65K 7.9K
Probiotec Ltd PBP:AU 58.54M 2.28M
Ramsay Health Care RHC:AU $ 1.79B 47M
ResMed RMD:AU $ 373.3M 17.25M
Sigma Healthcare Ltd SIG:AU 1.6B 19.99M
Sonic Healthcare SHL:AU $ 810.97M 24.83M
Telix Pharmaceuticals Ltd TLX:AU 1.67M 798K